Genomics

Dataset Information

0

Resistance to Palbociclib involves multiple mechanisms amenable to targeting with drug holidays or drug switching to improve therapeutic outcome [Affymetrix]


ABSTRACT: Combination of CDK4/6 inhibitors and endocrine therapy has been shown to improve clinical outcome in advanced estrogen receptor-positive breast cancer. However, not all patients will benefit and relapse is inevitable making the identification of new therapeutic strategies/biomarkers of particular importance.

ORGANISM(S): Homo sapiens

PROVIDER: GSE99002 | GEO | 2020/06/23

REPOSITORIES: GEO

Similar Datasets

2020-05-12 | GSE98987 | GEO
2020-05-12 | GSE99003 | GEO
2020-03-25 | PXD005611 | Pride
| PRJNA386948 | ENA
2019-09-13 | E-MTAB-7866 | biostudies-arrayexpress
2019-08-23 | GSE133567 | GEO
2017-01-01 | GSE87006 | GEO
2017-01-01 | GSE87007 | GEO
2023-07-10 | GSE229146 | GEO
2019-08-23 | GSE133568 | GEO